INTRODUCTION AND OBJECTIVES:
The goal of this study was to test the hypothesis that the low capacity ( 400 ml) bladder mucosal gene expression profile represents a bladder-centric IC/BPS sub-phenotype. This hypothesis is based on data from our previously reported pilot study showing that a subset of IC/BPS patients (those with a severely diminished bladder capacity {BC; 400 ml}) displayed a unique gene expression profile.
METHODS: Selection of female IC/BPS patient biopsy samples from our tissue bank (IRB00018552) for gene expression profiling was made on the basis of anesthetic bladder capacity. All patients had undergone therapeutic bladder hydrodistention per the AUA guideline algorithm. There were 3 groups: (1) low capacity group (BC 400 ml; N¼13), (2) BC between 450-1500 ml (N¼28) and, (3) control group (non-IC/BPS patients undergoing a pelvic reconstruction procedure; N¼7). Total RNA was isolated from mucosal biopsies (per standard protocols) and assayed on whole genome microarrays (Illumina HT v4 BeadArray).
RESULTS: Mucosal gene expression profiles differ significantly between controls and IC/BPS patients ( Figure 1A ). Key differences in the Epithelial Adherens Junction Signaling pathway were apparent (p ¼ 5.14E-05) between these two groups. Among only IC/BPS patients, gene expression profiles were also significantly different between those with a low capacity compared to those with BC > 400 ( Figure 1B) . One striking pathway impacted in this comparison was the EIF2 Signaling (eukaryotic translation initiation factor) pathway (p ¼ 8.2E-26). Finally, gene expression profiles in the low BC group with Hunner 0 s lesions were significantly different from those without lesions ( Figure 1C ). Not surprisingly, differential expression analysis produced inflammatory disease (p ¼ 1.46E-9) as a top classifier in this group comparison.
CONCLUSIONS: Mucosal gene expression in low anesthetized bladder capacity patients is distinct from gene expression profiles in higher capacity samples and from controls. These findings suggest low BC patients, with or without Hunner 0 s lesions, represent a sub-phenotype of IC/BPS and these gene expression differences, if confirmed, may yield additional therapeutic targets for this bladder-centric phenotype. METHODS: The clinical data of IC patients underwent hydrodistension (HD) plus bladder biopsy from 2009 to 2016 at our center were reviewed. The IC was diagnosed as: 1.pressure or pain at bladder accompanied by frequency and nocturia six weeks; 2. glomerulation or Hunner's ulcer on cystoscopy; 3. exclusion of other disease by pathology. The UPOINT scoring (Urinary symptom, Psychosocial symptom, Organ-specific symptom, Infection, Neurologic symptom and Tenderness) was assessed. HD outcomes were evaluated according to global response assessment (GRA) and UPOINT at postoperative 3 mo. The inflammation degree was semi-quantitatively assessed on Haematoxylin and eosin (H&E) staining. The immunohistochemistry (IHC) for PD-L1 expression dection and immunofluorescence for T cell and B cell counting were performed.
Source of
RESULTS: The present study includes 8 males and 32 females with median age of 57 years. The inflammation degree of the bladder wall on H&E is negatively correlated with disease course (P¼0.026) and positively correlated with the bladder pain degree (P<0.001). HD is effective at postoperative 3 mo in 19 subjects (GRA2), whose UPOINT scores indicate a highest relief rate of the bladder pain (89.5%, 17/19) followed by urinary symptoms (52.6%, 10/19). There are 17, 15, 7 and 1 subjects having none, mild, moderate and high degree of PD-L1 expression ( fig. A) . And PD-L1 expression degree is correlated with H&E inflammation degree and T cell count (fig. B) . Further, PD-L1 expression degree and T cell count are positively correlated with the bladder pain degree (fig. B) . Among the 12 subjects with severe inflammation on H&E, HD is more effective for subjects with moderate or high PD-L1 expression (83.3% vs. 16.7%, P¼0.04) (fig. C) .And subjects with moderate or high PD-L1 expression tended to have more effective hydrodistension outcome than subjects without PD-L1 expression (7/8 vs. 7/17, P¼0.038).
CONCLUSIONS: PD-L1 expression is more common in IC patients with serious bladder pain and severe bladder inflammation. IC patients with higher degree of PD-L1 expression tend to have more effective HD outcome.
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